Report: The Pharmaceutical Market: China (ESP00225) from ReportBuyer.com

Product Code	ESP00225
Publication Date	May 2010
Publisher	Espicom
Product Type	Report
Pages	74

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.

Specialised intelligence on OTCs, generics, biologics and biosimilars.

Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.

A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Executive Summary
- Snapshot: Key Data Projections
- Macroenvironment
- Political
- Economic
- Projections
- Legal
- Administrative Protection
- China Remains on USTR Priority Watch List
- Demographic
- Projections
- Demographic Indicators
- Births
- Deaths
- Infant Deaths
- Life Expectancy at Birth
EPIDEMIOLOGY
DISEASE BURDEN
- Leading Causes of Mortality
DISEASE PREVALENCE
- Communicable Diseases
- HIV/AIDS
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS
ORGANISATION
- Healthcare Reform Plan
- Ministry of Health
- Hospitals
- Rural Healthcare
- Red Cross Society of China
EXPENDITURE
- Projections
- Latest Figures
- Health Insurance
- Public Health Insurance
- Private Health Insurance
INFRASTRUCTURE
SERVICES
- Inpatient Analysis
- Outpatient Analysis
WORKFORCE
- Projections
- Current State
REGULATORY AFFAIRS
NATIONAL AUTHORITY
- Department of Drug Registration
- Regulatory Developments
- Revised Provisions for Drug Registration
- Q2 2010
- WPM
- China
- Revised GMP Regulations
MARKETING REGISTRATION
- Drug Classification
- New Regulatory Legislation
- 2001 DAL Amendments
- The Drug Import Regulation
- GMP Regulations
- Drug Approval Process
- Clinical Trials
- Quality Tests
- Certification
- POST-MARKETING SURVEILLANCE
- Revoked Licences
- Bribery Cases
PROMOTION
- Advertising
PACKAGING
PRICING & REIMBURSEMENT
PRICING
- National Pricing
- Provincial Pricing
REIMBURSEMENT
- New Reimbursement Policy
- China's National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Medicine Directory
- 29
DISTRIBUTION CHANNELS
DRUG WHOLESALING
- Leading Wholesalers
- Alliance Boots
- index
- Hainan Kangtong Pharmaceutical
- Huazhong Pharmaceutical
- Hunan Provincial Medicines & Health Products Import & Export Corp
- Jointown Pharmaceutical Group
- Nanjing Medical Company (NMC)
- Shandong Medicines & Health Products Import & Export Corp
- Sincer Pharmchem
- Sinochem Jiangsu Suzhou Import Export Corp
- Sinopharm
- Tianjin Medicines & Health Products Import & Export Corp
DRUG RETAILING
- Leading Pharmacy Chain
- ShenZhen Nepstar
MARKET ANALYSIS
- SIZE
- Projections
- Current Size
PRODUCT DEVELOPMENT
- SFDA Initiatives
- Solvay
- Zhangjiang Hi-Tech Park
- Beijing Union Pharmaceutical Factory
- Q2 2010
- WPM
- China
- New R&D Investment
MANUFACTURING
- 11th Five Year Plan Targets
- China to Turn Five Companies into International Producers
- TRADE
- Exports
- Imports
- Balance of Trade
COMPETITION
TRADE ASSOCIATIONS
- CAPC
- CPIA
- RDPAC
- RDPAC Members, 2010
TRADE FAIRS
- Interphex China
- PharmChina
COMPANY INTELLIGENCE
- Domestic Manufacturers
- Aida Pharmaceuticals
- Beijing Four Ring Biopharmaceutical
- Changzhou Siyao Pharmaceuticals
- China National Pharmaceuticals Group Corp (Sinopharm)
- China Pharmaceutical Group
- CSPC Weisheng Pharmaceutical Company
- Fuzhou Antibiotic Group Corp
- Haizhou Pharmaceutical
- Heshuo Ephedrine Factory
- Huazhong Pharmaceutical
- Jiangsu Jiangan Pharmaceutical
- Ningbo Jierfu Pharmaceutical
- North China Pharmaceutical Huasheng
- Shanghai Pharmaceutical Group
- Shenzhen Zhijun Pharmaceutical Company
- Shenzhen Taitai Pharmaceutical Industry (Taitai)
- Simcere Pharmaceutical Group
- Wenzhou Pharmaceutical Factory
- Xiamen No 2 Pharmaceutical Factory
- Xinhua Pharma
- YiYuan Pharmaceutical
- Zhejiang Jinhua Lixin Fine Chemicals
- Zhejiang Medicine Company
Multinational Manufacturers
- Allergan
- Antibioticos
- Astellas Pharma
- AstraZeneca
- Boehringer Ingelheim
- Bayer
- Bristol-Myers Squibb
- Daiichi Sankyo
- Dainippon Sumitomo Pharma
- Dragon Pharmaceuticals
- Q2 2010i
- WPM
- China
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Hovione
- Johnson & Johnson
- Merck Sharp & Dohme
- Mitsubishi Tanabe Pharma
- Novartis
- Novo Nordisk
- Pfizer
- Rexim SA (Degussa)
- Roche
- sanofi-aventis
- Schering-Plough
- Servier
- Takeda
- Wyeth
OTC PHARMACEUTICALS
REGULATION
MARKET SIZE
COMPETITION
- China Sky One Medical
- Harbin Pharmaceutical Group
TRADITIONAL CHINESE MEDICINE
- China Conducts Research on Toxicity and Side Effects of TCM
GENERIC PHARMACEUTICALS
REGULATION
- Prescribing Regulation
MARKET SIZE
COMPETITION
- Company Intelligence
- China Pharma Holdings
- Desano
- Merck KGaA
- Ranbaxy
- Watson
BIOLOGICS & BIOSIMILARS
REGULATION
MARKET SIZE
COMPETITION
- Company Intelligence
- 3SBIO
- Anhui Anke Biotech
- China Biologic Products
- GeneScience
- Genzyme
- GlaxoSmithKline
- Livzon (Group) Libao Biochemical & Pharmaceutical
- Merck Serono
- Microbix
- NeoStemii
- Q2 2010
- WPM
- China
- Shenzhen Kexing Biotech
- Simcere
- Sinobiopharma
- Sinovac Biotech
- Wuyi JiuYuan
CONCLUSIONS: OPPORTUNITIES & CHALLENGES
- Macroenvironment
EPIDEMIOLOGY
HEALTHCARE
REGULATORY AFFAIRS
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
- MARKET
COMPETITION
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
- Radar Analysis
- SWOT Analysis
DIRECTORY
GOVERNMENT ORGANISATIONS
PHARMACEUTICAL PRODUCERS
- Foreign Pharmaceutical Producers
- Local Pharmaceutical Producers
TRADE ORGANISATIONS
- Q2 2010iii
- WPM
- China
List of tables
- Key Data Projections, 2010-2015
- Political Landscape, 2010
- Regional Comparison of Projected Economies, 2015
- Projected Economy, 2010-2015
- Regional Comparison of Projected Demographics, 2015
- Projected Demographics, 2010-2015
- Summary of Demographic Indicators, 2006-2007
- Demographic Indicators, 2001-2007
- Leading Causes of Death, 2007
- Reported Infectious Diseases, 2001-2007 (Rate/100,000 Pop )
- Regional Comparison of Projected Health Expenditure, 2015
- Projected Health Expenditure, 2010-2015
- Healthcare Expenditure, 2006
- NCMS Funding and Expenditure, 2005
- Hospitals & Beds, 2007
- Beds by Region (Including Municipalities), 2007
- Admissions, 2002-2007 (Millions)
- Hospital Admissions by Establishment, 2007 (000s)
- Hospital Bed Utilisation, 1997-2007
- Outpatient Visits by Establishment, 2005
- Regional Comparison of Projected Physicians, 2015
- Projected Number of Physicians, 2010-2015
- Medical Personnel by Region (Including Municipalities), 2007
- ShenZhen Nepstar Drugstores by City, 2006-2008
- Regional Comparison of Projected Pharmaceutical Markets, 2015
- Projected Pharmaceutical Market, 2010-2015
- Summary of the Chinese Pharmaceutical Market, 2010
- TCM Industrial Output Value, 2000-2007 (CNY Billion)
- Pharmaceutical Exports by Category, 2004-2008 (US$000s)
- Pharmaceutical Exports by Country/Region, 2008 (US$000s)
- Pharmaceutical Imports by Category, 2004-2008 (US$000s)
- Imports of Raw Materials by Country/Region, 2008 (US$000s)
- Imports of Antisera & Vaccines by Country/Region, 2008 (US$000s)
- Imports of Medicaments by Country/Region, 2008 (US$000s)
- Pharmaceutical Balance of Trade, 2004-2008 (US$000s)
- Dragon Pharmaceuticals Revenues by Segment, 2009 (US$ 000s)
- SWOT Analysis of the Pharmaceutical Market, 2010
List of Charts
- China's Pharmaceutical/Medical Device Industry Output, 1998-2007 (CNY100 Million)
- Pharmaceutical Exports, 2003-2008 (US$ Billions)
- Pharmaceutical Imports, 2003-2008 (US$ Billions)
- Pharmaceutical Imports by Country/Region, 2008 (%)
- Pharmaceutical Balance of Trade, 2003-2008 (US$ Billions)
- Radar Graph of the Pharmaceutical Market, 2010